fda-approved

Mesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) TherapyMesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy

Mesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy

December 18, 2024 19:08 ET  | Source: Mesoblast Limited RYONCIL (remestemcel-L) is the first MSC product approved by FDA for…

4 months ago
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheterTexas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center…

5 months ago
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheterTexas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center…

5 months ago